申请人:Novo Nordisk A/S
公开号:US06004983A1
公开(公告)日:1999-12-21
The present invention relates to novel N-substituted azaheterocyclic carboxcylic acids of the general formula wherein X, Y, Z, R.sup.1, R.sup.2 and r are as defined in the detailed part of the description, or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for treatment of indications caused by or related to the secretion and circulation of insulin antagonising peptides.
本发明涉及新的N-取代的杂环羧酸类化合物,其一般化学式为X、Y、Z、R.sup.1、R.sup.2和r所定义,或其盐,以及它们的制备方法、含有它们的组合物,以及它们在临床治疗中用于治疗C纤维发挥病理生理作用引起的疼痛、高度痛感和/或炎症病症,以及它们用于治疗由胰岛素拮抗肽分泌和循环引起或相关的症状。